Balchem Corporation to Present at the HC Wainwright & Co. 26th Annual Global Investment Conference on September 9, 2024

Rhea-AI Summary

Balchem (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, has announced its participation in the HC Wainwright & Co. 26th Annual Global Investment Conference on September 9, 2024. The company will be represented by key executives including Ted Harris (Chairman of the Board, President and CEO), Martin Bengtsson (CFO), and Allison Baurichter (Senior Director Investor Relations).

This presentation at a prominent investment conference provides an opportunity for Balchem to showcase its business strategies, financial performance, and growth prospects to potential investors and industry analysts. The event could potentially impact Balchem's stock performance and investor relations.

News Market Reaction – BCPC

+2.93%

+2.93% Session move

In the trading session that priced this news, BCPC gained 2.93%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MONTVALE, N.J., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the HC Wainwright & Co. 26th Annual Global Investment Conference on September 9, 2024. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will present at the conference.

About Balchem Corporation

Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.

Contact:		Jacqueline Yarmolowicz Balchem Corporation (Telephone: 845-326-5600)

FAQ

When is Balchem (BCPC) presenting at the HC Wainwright & Co. Global Investment Conference?

Balchem (BCPC) is presenting at the HC Wainwright & Co. 26th Annual Global Investment Conference on September 9, 2024.

Who will be representing Balchem (BCPC) at the investment conference?

Balchem (BCPC) will be represented by Ted Harris (Chairman, President and CEO), Martin Bengtsson (CFO), and Allison Baurichter (Senior Director Investor Relations) at the conference.

What is the significance of Balchem (BCPC) presenting at the HC Wainwright & Co. conference?

Presenting at this conference allows Balchem (BCPC) to showcase its business strategies, financial performance, and growth prospects to potential investors and industry analysts, potentially impacting its stock performance and investor relations.

What markets does Balchem (BCPC) serve as a specialty ingredient manufacturer?

Balchem (BCPC) is a global specialty ingredient manufacturer serving health and nutrition markets.